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nerves (ICN).Background ICN cluster around the left atrial epicardium and are implicated in the genesis of atrial ﬁbrillation (AF).Methods Patients undergoing catheter AF ablation underwent adjunctive ethanol injection in the VOM. A multipolar
catheter was introduced in the VOM and used for high-frequency stimulation (HFS), either as HFS with P-wave
synchronized (SynchHFS), 30 pulses, 100 Hz (n ¼ 8) or as HFS with 3 to 10 s bursts (BurstHFS), 33 Hz (n ¼ 72)
at 25 mA for 1-ms duration. Atrioventricular (AV) nodal conduction slowing (asystole >2 s or R-R interval
prolongation >50%) and AF inducibility were assessed before and after VOM ethanol infusion. Up to 4 1-ml
infusions of 98% ethanol were delivered via an angioplasty balloon in the VOM.Results SynchHFS induced AF in 8 of 8 patients. In 4 of 8 AF initiated spontaneously without VOM capture. No parasympathetic
responses were elicited by SynchHFS. BurstHFS was performed in 32 patients undergoing de novo AF ablation (Group
1) and 40 patients undergoing repeat ablation (Group 2). Parasympathetic responses were found in all 32 Group 1
patients and in 75% of Group 2 patients. After VOM ethanol infusion, parasympathetic responses were abolished in
all patients (both groups). There were no acute complications related to VOM ethanol infusion.Conclusions The VOM contains ICN that connect with the AV node and can trigger AF. Retrograde ethanol infusion in the
VOM reliably eliminates local ICN responses. The VOM is a vascular route for ICN-targeting therapies. (J Am
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physiology in a pro-ﬁbrillatory manner (1). ICN ablation has
been proposed as an adjunctive (2) or stand-alone (3) ther-
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techniques.See page 1902ICNs cluster in discrete ganglia located in the proximity of
the pulmonary veins (PV). The ligament of Marshall is
considered part of the ICN (4). It has been shown to contain
sympathetic (5) and parasympathetic (6) innervation, and
it coincides with regions known to harbor ICN, speciﬁcally
the left dorsal nerve (7). It becomes the vein of Marshall
(VOM) caudally as it connects with the coronary sinus. The
ligament of Marshall has been implicated in the genesis
of AF by multiple mechanisms: as a source of ectopic beats
initiating AF (8–10), as a connection pathway with
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1893neighboring myocardium and left PV (5,11), and as a source
of arrhythmogenic autonomic innervation (5,6). Animal (12)
and human (3) surgical open-chest studies have shown that
high-frequency electrical stimulation (HFS) at the ligament
of Marshall area may induce parasympathetic responses
characterized by signiﬁcant slowing of atrioventricular (AV)
nodal conduction and AF induction. It is not known whether
the VOM can anatomically connect with the ICN associated
with the ligament of Marshall. If so, then the VOM could
be used as a closed-chest endovascular route to the ICN for
therapeutic purposes. We have developed a technique for
retrograde VOM ethanol infusion and have shown its
feasibility and safety in humans (13,14). We hypothesized
that: 1) HFS performed within the VOM can elicit para-
sympathetic responses; and 2) the VOM can be used as a
vascular route to target these epicardial ICN and regionally
denervate the LA with chemical ablation.
Methods
Patients. We enrolled 133 patients in the VOM ethanol
infusion procedure. Patients were undergoing clinically
indicated PV antral isolation (PVAI) and gave consent for
adjunctive ethanol injection in the VOM in a protocol that
was approved by the local institutional review board, over-
seen by the Food and Drug Administration (IND #105083),
and an external Data Safety Monitoring Board.
Procedural strategy. After obtaining informed consent,
patients were subjected to general anesthesia, and vascular
access was obtained. A quadripolar catheter was positioned
in the His bundle and a decapolar catheter in the coronary
sinus via a femoral vein.
The VOM was cannulated as previously described
(13,14). Brieﬂy, the right internal jugular vein was
accessed with a 9-F sheath. Then, a sheath designed for
left ventricular pacing lead delivery was inserted in this
sheath and into the coronary sinus (CPS sheath, St Jude
Medical, Minneapolis, Minnesota). A subselector catheter
(LIMA angioplasty guide) was then inserted through the
CPS sheath and manipulated so that its tip faced poste-
riorly and superiorly. Angiographic contrast was injected
through the LIMA guide, and the VOM was identiﬁed as
an atrial branch of the coronary sinus that arose at the
level of the valve of Vieussens and that was directed
posteriorly.
A quadripolar catheter (1.7-F Pathﬁnder Mini, Cardima,
or 4-F IBI [St. Jude Medical]; or 2.4-F over-the-wire
[Internova Medical, Chiba, Japan]) was inserted in the
VOM through the LIMA guide. This catheter was used to
record baseline VOM electrocardiograms and to perform
HFS. A transseptal puncture was then performed under
intracardiac echocardiographic guidance, and a circular
duodecapolar catheter was inserted in the left atrium.
Heparin was administered to maintain the activated clotting
time between 350 and 400 s throughout the procedure.
Three-dimensional maps of the left atrial geometry andregional bipolar voltage ampli-
tude were constructed at baseline
and after VOM ethanol admin-
istration with either NavX (St.
Jude Medical) or Carto 3 (Bio-
sense-Webster, Diamond Bar,
California) mapping systems.
High-frequency stimulation
protocols. PROTOCOL 1. To avoid
atrial capture, VOM HFS was
performed during atrial refrac-
toriness (15), delivering atrium-
synchronized HFS (SynchHFS;
sensing in the proximal coronary
sinus) stimulation (30 pulses at 100
Hz). Spontaneous (non-captured)
atrial activity was monitored
subsequently.
PROTOCOL 2. Prolonged (3- to 10-s) bursts at 33 Hz
(BurstHFS) were delivered via the VOM.
Both protocols were delivered at 25 mA of amplitude
and 1-ms pulse width. A positive parasympathetic response
was deﬁned as either AV block or asystolic pause >2 s or a
bradycardic response manifested as R-R interval prolonga-
tion by >50% when averaging 15 beats before and after
HFS. Local AF inducibility with HFS was assessed pre- and
post-ethanol infusion in the VOM. If AF persisted beyond
the VOM ethanol administration, local AF inducibility with
HFS could not be tested.
VOM ethanol infusion procedure. The quadripolar
catheter was then retracted from the VOM, and an angio-
plasty wire (BMW, Abbott, Abbott Park, Illinois) was
advanced into the VOM as distally as possible. A pre-loaded
angioplasty balloon (8-mm length, 2-mm nominal diameter
[Voyager OTW, Abbott] or 6-mm length, 1.5 mm diameter
[Medtronic, Minneapolis, Minnesota]) was advanced over
the wire, as distally as possible. Depending on the length
of the VOM, up to 4 injections of 98% ethanol (1 cc over 2
min each) were delivered. Starting in the most distal VOM,
the balloon was slightly retracted sequentially after each in-
jection so that the last injection was given from the most
proximal VOM. After ethanol infusion, the angioplasty wire
and balloon were retracted, and the quadripolar catheter was
reinserted into the VOM to record signals and repeat HFS
with the same protocol used prior to ethanol administration.
Ethanol levels were measured in mixed venous blood at
the end of the procedure. Beyond VOM instrumentation,
the procedure continued with radiofrequency ablation using
a Thermocool catheter (Biosense-Webster) navigated with
the Artisan robotic sheath (Hansen Medical, Mountain
View, California). Radiofrequency ablation with a power of
25 to 35 W and saline irrigation at a rate of 17 to 30 cc/min
were performed as needed in each case to isolate the PVs,
ablate complex-fractionated potentials, or LA ﬂutters if
present.
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1894Statistical analyses. Data are mean  SD. Student t test
was used to compare means. Proportions were compared
with chi-square or Fisher exact test where appropriate. A
p value of <0.05 was considered signiﬁcant.
Patient follow-up. Patients were followed clinically at 1,
3, 6, and 12 months post-procedure and as needed for
clinical recurrences. Continuous 4-week event monitors
were connected routinely at 3 and 12 months and as needed
for symptomatic arrhythmias.Results
All patients were brought to the electrophysiology laboratory
for clinically indicated catheter ablation of AF after being
treated with antiarrhythmic drugs and cardioversions as
necessary prior to the procedure. The VOM was successfully
cannulated in 119 of 133 patients (89%). We were able to
complete either of the HFS protocols before and after VOM
ethanol infusion in a total of 80 patients (8 in protocol 1 and
72 in protocol 2), which are reported in this study. In the
remaining patients, HFS protocols were not completed due
to inability to introduce a quadripolar catheter in the VOMFigure 1 Results Summary
(A) P-wave-synchronized high-frequency stimulation (SyncHFS) protocol. (B) BurstHFS ¼
See text for details. *p < 0.05 compared with distribution in Group 1. #p ¼ NS compare(Pathﬁnder mini-catheter was not manufactured after 2010)
or to complete the pre- and post-ethanol VOM HFS pro-
tocols. Figure 1 summarizes the results.
Protocol 1. A total of 8 patients who had previously un-
dergone catheter ablation procedure underwent SynchHFS,
which induced AF in all patients when atrial capture was
obtained. In 4 of 8 patients, AF spontaneously initiated after
noncapturing, short SynchHFS trains, and in all 4 cases,
AF-initiating atrial premature contractions were recorded
ﬁrst in the VOM (Fig. 2). VOM ethanol infusion abolished
AF induction upon repeating SynchHFS (Fig. 2B). Because
of the inability to assess parasympathetic responses (which
relied on effects on AV conduction) with this protocol, it
was abandoned for subsequent patients.
Protocol 2. GROUP 1: DE NOVO AF ABLATION. Group 1
included 32 patients undergoing AF catheter ablation for
the ﬁrst time. AF was paroxysmal in 19 of 32 patients
and persistent in 13. Mean age was 63  8 years, and
9 patients were female. BurstHFS led to AF induction in
all patients. Parasympathetic responses were assessed dur-
ing induced AF and were elicited in all patients, either as
an asystolic response (4.7  2.3 s) in 23 of 32 patients or ashigh-frequency stimulation with 3- to 10-s bursts, 33 Hz (BurstHFS) protocol.
d with Group 1. {p < 0.05 compared with Group 1.
Figure 2 SynchHFS Inducing AF Without Atrial Capture, and Abolition of AF Induction After VOM Ethanol
(A) At baseline (Pre-ethanol), 30 stimuli at 100 Hz following the P wave (sHFS) did not capture the atrium. After a sinus beat, atrial ﬁbrillation (AF) ensues, with the ﬁrst beat
arising from the VOM location. (B) After VOM ethanol infusion, SynchHFS failed to induce AF. (C) Procedural sequence: right anterior oblique ﬂuoroscopic views of the
intracardiac catheters. (Top panel) A quadripolar catheter was inserted in the VOM for baseline HFS and VOM signal recording. (Middle panel), an angioplasty balloon is inserted
in the VOM for selective angiograms and ethanol infusion. (Bottom panel) Repeated quadripolar catheter insertion in the VOM for post-ethanol HFS. CS ¼ coronary sinus;
d ¼ distal; HRA ¼ high right atrium; LIPV ¼ left inferior pulmonary vein; p ¼ proximal; VOM ¼ vein of Marshall.
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Figures 3 and 4 show examples of asystole and RR pro-
longation elicited upon VOM BurstHFS, respectively.
AF was induced in all patients during HFS and subse-
quently terminated in 27. After VOM ethanol infusion
and AF, or any atrial arrhythmia, was not reinducible by
VOM HFS in those 27 patients (Figs. 3B and 4B), and
parasympathetic responses were not obtained in any of
the 32 patients.
GROUP 2: REPEATAF ABLATION. Group 2 included 40 patients
undergoing a repeat AF catheter ablation procedure. AF
had been paroxysmal in 19 of 40 and persistent in 21. Mean
age was 64  9 years, and 12 patients were female. Except
for the proportion of persistent versus paroxysmal AF (p <
0.001), none of the patient characteristics was statistically
different from those of Group 1. Clinical failures of a pre-
vious catheter ablation procedure (1.3  0.5 prior pro-
cedures) had been due to ﬂutter in 22 of 40 patients.
BurstHFS in the VOM during sinus rhythm or atrial
ﬂutter led to AF induction in all patients at the initiation of
HFS (4 required previous cardioversion for AF). Para-
sympathetic responses were triggered by BurstHFS in 30 of
40 patients: in 9 patients an asystolic response was obtained
(4.5  1.7 s, p ¼ nonsigniﬁcant compared to asystolic re-
sponses of Group 1 patients); and in 21 patients, an RRprolongation was obtained (194  21 %, p < 0.05 compared
to RR prolongation obtained in Group 1 patients). Figures 5
and 6 show examples of asystolic and RR-prolongation re-
sponses, respectively. The distribution of asystolic versus RR
prolongation responses of Group 2 contained a greater
proportion of RR prolongation responses (and of no para-
sympathetic responses) than that of Group 1 patients (p <
0.05).
Local AF inducibility with VOM HFS was reassessed
post-ethanol injection. Thirteen patients remained in sus-
tained AF after ethanol injection in the VOM, and induc-
ibility could not be tested with repeat HFS (cardioversion
was not performed). In the other 27 patients who had either
cardioversion performed or the initial AF was nonsustained,
inducibility was reassessed. In this group, AF, or any atrial
arrhythmia, remained noninducible via VOM HFS in 27 of
27 patients (100%) (Figs. 1, 5B, and 6B). Parasympathetic
responses were eliminated in all patients after VOM ethanol
injection.
Acute procedural outcomes. There were no complications
directly attributable to VOM instrumentation or ethanol
infusion. Ethanol levels measured in mixed venous blood at
the end of the procedure were undetectable in all patients.
Fluoroscopy and procedure times required to complete the
VOM component of the procedure were 9.6  5.2 min and
Figure 3 Asystolic Response to BurstHFS in a Patient Undergoing de novo AF Ablation (Group 1)
(A) Procedural sequence from left to right. Right anterior oblique views. A quadripolar 1.7-F catheter is inserted in the vein of Marshall (VOM), identiﬁed by nonselective contrast
injection through the LIMA angiographic guide in the coronary sinus. Baseline high-frequency stimulation (HFS) was performed. Next, an angioplasty balloon was inserted for the
VOM venogram and ethanol infusion at up to 4 locations, from distal to proximal. Finally, repeated insertion of the quadripolar catheter for HFS was done. (B) Pre-ethanol
response to BurstHFS. Surface electrocardiogram and coronary sinus (CS) signals are shown. BurstHFS led to asystole of 5.7 s and induction of AF. (C) After ethanol infusion,
BurstHFS failed to induce parasympathetic responses or AF. d ¼ distal; p ¼ proximal.
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189662.5  12.5 min, respectively. Ethanol led to elimination
of VOM signals in all patients and to the creation of a low-
voltage area (bipolar voltage <0.1 mV) in the endocardial
surface of 8.8  4.1 cm2, located between the coronary sinus
and the left inferior pulmonary vein (Fig. 7). The left infe-
rior pulmonary vein was disconnected in 18 of 32 patients in
Group 1, solely with VOM ethanol infusion. In Group 2, 32
of 40 patients had left inferior pulmonary vein (LIPV)
reconnection, and in 23 of 32 patients VOM ethanol led to
re-disconnection (16). Overall, average radiofrequency time
required to disconnect the LIPV was 2.9  1.2 min,
compared with 16.1  8.2 min required to isolate each of
the remaining veins (p < 0.05) (17).
Patient follow-up. Patients were followed for a mean
of 24.6  12.5 months. On follow-up, 1 patient developed
pleuropericarditis similar to Dressler’s syndrome: at 2 weeks
post-ablation, the patient presented with bilateral pleural
effusions and chest pain consistent with pericarditis but
without pericardial effusion or any other abnormal ﬁndings
on chest contrast computerized tomography. He responded
to anti-inﬂammatory agents and colchicine. Two patientshad chest pain and pericardial effusions requiring drainage
at 2 and 4 weeks post-ablation. All patients had received
conventional radiofrequency ablation concomitantly (with
the use of a robotic sheath) that may have contributed to
pericardial effusions. Seventy-eight percent of all patients
completed electrocardiographic monitoring as requested
(100% of 14 patients with symptoms). AF recurrence
occurred in 6 of 32 patients in Group 1, and all had pul-
monary vein reconnections in a repeat procedure, including
1 patient who had the LIPV disconnected with ethanol. In
Group 2, 8 of 40 patients had recurrent atrial tachyar-
rhythmia episodes, 2 had AF, and 6 had atrial ﬂutters
(roof-dependent, LA appendage atrial tachycardia, and
right atrial ﬂutter, 2 each) which underwent successful
repeat ablation.
Discussion
The main ﬁndings of our study are: 1) the VOM and its
neighboring atrial myocardium contain ICN that can
reach the AV node and induce parasympathetic responses;
Figure 4 Bradycardic (RR Prolongation) Response to BurstHFS in a Patient Undergoing De Novo AF Ablation (Group 1)
(A) Catheter location in right anterior oblique view. A septal occluder device was also present. (B) Pre- and post-ethanol recordings. Atrial ﬁbrillation (AF) had been previously
induced, and signiﬁcant RR prolongation was induced by BurstHFS. Such a response was abolished after ethanol injection.
Figure 5 Asystolic Response to BurstHFS in a Patient Undergoing Repeat AF Ablation (Group 2)
(A) Catheter is shown in the right anterior oblique view. (B) Pre- and post-ethanol recordings. AF had been previously induced, and a 5.35-s asystole was induced by BurstHFS.
Such a response was abolished after ethanol injection.
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Figure 6 Bradycardic (RR Prolongation) Response to BurstHFS in a Patient Undergoing Repeat AF Ablation (Group 2)
(A) Catheter is shown in the right anterior oblique view. (B) Pre- and post-ethanol recordings. AF had been previously induced, and signiﬁcant RR prolongation was induced
by BurstHFS. Such a response was abolished after ethanol injection.
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without local atrial capture; 3) VOM HFS-induced para-
sympathetic responses are less common in patients with
prior catheter AF ablation, suggesting that neuronal damage
can occur during a PVAI procedure; and 4) VOM ethanol
infusion eliminates parasympathetic responses and AF in-
duction, consistent with regional left atrial denervation.
These ﬁndings support the feasibility of VOM cannulation
as a percutaneous technique for endovascular delivery of
ICN-targeted therapies.
The anatomical distribution of the ICN is complex. ICNs
are reported to cluster in distinct ganglionated plexi in the
vicinity of the PV ostia. It is important to recognize the
distinction between the extracardiac ligament of Marshall,
a remnant of the left superior vena cava, and the intracardiac
VOM. The ligament of Marshall is known to be a conduit
for sympathetic (5) and parasympathetic (6) extrinsic cardiac
nerves, and it coincides with the left dorsal cardiac nerve.
Stimulation of the ligament of Marshall can induce atrial
ﬁbrillation and even ventricular arrhythmia (15) presumably
by direct activation of such extrinsic nerves. The VOM,
although in continuity with the ligament of Marshall, is
an intracardiac structure in direct connection with the cor-
onary sinus. ICN reached by VOM HFS may include not
only those ICN clustered in the VOM-posterolateral left
atrial ganglionated plexus (18) but also those associated
with the inferior left ganglionated plexus. Depending on
the VOM length, even extrinsic cardiac nerves of theligament of Marshall may be reached. Regardless of which
ICN are stimulated by VOM HFS, in order to lead to AV
node conduction slowing, those VOM-associated ICN need
to communicate with the right inferior PV plexus, which
is the one directly communicating with the AV node
(19,20). Thus, eliciting a parasympathetic response in the
AV node by VOM HFS proves not only local ICN stim-
ulation but also the existence and activation of interneuronal
communications between different ICN. These ﬁndings
are consistent with those of Lin et al. (12), who found, in
a canine study using HFS, that both the ligament of
Marshall and the inferior left ganglionated plexus modulate
AV nodal conduction.
Induction of AF by local VOM HFS without local atrial
capture is a more complex phenomenon. A conceivable
pathophysiological conjecture is that SynchHFS can selec-
tively stimulate local ICN leading to acetylcholine release and
action potential shortening. Coincidental stimulation of local
adrenergic nerves could lead to local after-depolarization
and AF induction, as postulated by Patterson et al. (21).
The relative inconsistency of AF induction by this
SynchHFS (4 of 8 patients) may thus illustrate the multiple
pathophysiological steps required in its mechanism.
AF induced by BurstHFS was a consistent phenomenon,
but atrial capture is expected to have played a major role in
this setting. Either by local ICN ablation or atrial tissue
ablation, VOM ethanol eliminated AF inducibility by VOM
HFS.
Figure 7 VOM Electrocardiograms and Endocardial Bipolar Voltage Maps Before and After VOM Ethanol Infusion
(A) De novo ablation (Group 1). (B) Repeat ablation (Group 2). VOM signals are abolished and a large endocardial low-voltage area is created by ethanol.
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catheter ablation has been previously reported (22). Our data
showing a reduced incidence of parasympathetic responses
by VOMHFS is consistent with these previous observations.
VOM ethanol successfully eliminated parasympathetic
responses as well as AF inducibility. Selective radiofrequency
ablation of ICN has been shown to abolish the inducibility of
AF in humans (3) and to eliminate stimulation-induced
vagal responses (22). Additionally, autonomic denervation
with radiofrequency applications at sites that elicited a
parasympathetic response considerably increased the effec-
tiveness of PVAI in patients with paroxysmal AF (23). Even
anatomically remote modulation of the autonomic nervous
system such as renal denervation may have an impact on
ablation success (24). Our study is the ﬁrst to show abolition
of parasympathetic responses by using chemical ablation
rather than radiofrequency energy in humans. Ethanol is
highly cytotoxic when infused intravascularly and creates a
myocardial scar when delivered through either the coronary
venous or arterial route. It has been therapeutically used in
septal ablation for hypertrophic cardiomyopathy (25), abla-
tion of ventricular tachycardia via the coronary arteries
(26,27) or coronary veins (28,29), and ablation of the atrio-
ventricular node (30). The vagal denervating effects of
ethanol infusion in the VOM were initially studied by our
group in dogs. We showed that it can selectively abolish vagal
innervation of the left atrium by blunting vagally mediated
decreases in LA effective refractory periods (13). We havesubsequently shown the clinical usefulness of VOM ethanol
infusion in humans on both AF recurrences after catheter
ablation (16) and in the treatment of perimitral ﬂutter (31).
This is, to our knowledge, the ﬁrst demonstration of percu-
taneous chemical denervation of the left atrium in humans.
Clinical implications. Although still controversial, ablation
of ICN is a potential target in AF ablation (2). Ethanol
infusion in the VOM is attractive in ablation of AF because
local toxicity of ethanol is limited to tissues in direct contact
with it and spares neighboring structures such as the
esophagus. VOM ethanol infusion directly addresses mech-
anistic sources of AF located in the VOM, including
ectopic triggers (32). Our current data add atrial dener-
vation as an additional therapeutic effect of VOM
ethanol. Radiofrequency ablation can effectively eliminate
parasympathetic responses; when identiﬁed (23), it is tech-
nically simpler than VOM cannulation, which does not
eliminate its need. However, it is unclear whether ICN in the
VOM region can be readily ablated conventionally, given the
fact that VOM signals are often present after endocardial
radiofrequency in this region. (16) The ultimate role of
VOM ethanol infusion in the treatment of AF remains to be
determined and would only be established in a randomized
clinical trial assessing rhythm control outcomes.
An important implication of our study is that the
VOM can be used as a vascular route to deliver therapies
targeting the ICN. Ethanol is nonspeciﬁcally toxic to all
tissues exposed. However, other pharmacological strategies
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using the VOM as a route.
Study limitations. Due to its technical complexity, the
protocol (VOM cannulation, HFS pre- and post-ethanol)
could only be completed in 80 of 133 patients. Autonomic
nervous system activity analysis with tools such as heart rate
variability was not performed. The functional relevance of
ICN ablation remains to be determined, but that was
beyond the scope of our study. The physiological relevance
of interrupting neuronal connections is unclear, and it may
potentially be deleterious for AF (33) or ventricular ar-
rhythmias (34), although these were not observed on follow-
up. The patient group was widely heterogeneous and
included a wide range of left atrium sizes and AF patterns.
Although the acute procedural safety of VOM ethanol
infusion is clear, the long-term effects of ethanol and the
permanence of ethanol-induced ablation lesions are un-
known. It is clear that VOM ethanol infusion is an un-
conventional procedure that requires additional experience.
Most clinically relevant procedural endpoints achieved can
currently be achieved by radiofrequency. Only a randomized
clinical trial can prove whether VOM ethanol infusion
adds clinical beneﬁt to catheter ablation of AF.
Conclusions
The VOM contains ICN that connect with the AV node
and can trigger AF. Retrograde ethanol infusion in the
VOM causes regional LA parasympathetic denervation, by
abolishing local ICN responses and AF inducibility in
humans. The VOM is a vascular route for ICN-targeting
therapies.
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